Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling

G protein-coupled receptors (GPCRs) are cell surface proteins mainly involved in signal transmission; however, they play a role also in several pathophysiological conditions. Chemically heterogeneous molecules like peptides, hormones, lipids, and neurotransmitters activate second messengers and induce several biological responses by binding to these seven transmembrane receptors, which are coupled to heterotrimeric G proteins. Recently, additional molecular mechanisms have been involved in GPCR-mediated signaling, leading to an intricate network of transduction pathways. In this regard, it should be mentioned that diverse GPCR family members contribute to the adaptive cell responses to low oxygen tension, which is a distinguishing feature of several illnesses like neoplastic and cardiovascular diseases. For instance, the G protein estrogen receptor, namely G protein estrogen receptor (GPER)/GPR30, has been shown to contribute to relevant biological effects induced by hypoxia via the hypoxia-inducible factor (HIF)-1α in diverse cell contexts, including cancer. Likewise, GPER has been found to modulate the biological outcome of hypoxic/ischemic stress in both cardiovascular and central nervous systems. Here, we describe the role exerted by GPCR-mediated signaling in low oxygen conditions, discussing, in particular, the involvement of GPER by a hypoxic microenvironment.

[1]  A. Vivacqua,et al.  The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells. , 2016, Cellular signalling.

[2]  B. Bussolati,et al.  GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells , 2015, Oncotarget.

[3]  M. Maggiolini,et al.  Pregnancy Augments G Protein Estrogen Receptor (GPER) Induced Vasodilation in Rat Uterine Arteries via the Nitric Oxide - cGMP Signaling Pathway , 2015, PloS one.

[4]  A. Belfiore,et al.  Copper activates HIF-1α/GPER/VEGF signalling in cancer cells , 2015, Oncotarget.

[5]  P. Ratcliffe,et al.  HIF hydroxylase pathways in cardiovascular physiology and medicine. , 2015, Circulation research.

[6]  D. Aebersold,et al.  Interplay between receptor tyrosine kinases and hypoxia signaling in cancer. , 2015, The international journal of biochemistry & cell biology.

[7]  W. Xiang,et al.  Activation of novel estrogen receptor GPER results in inhibition of cardiocyte apoptosis and cardioprotection , 2015, Molecular medicine reports.

[8]  H. Feng,et al.  G-protein-coupled receptor 30-mediated antiapoptotic effect of estrogen on spinal motor neurons following injury and its underlying mechanisms , 2015, Molecular medicine reports.

[9]  E. D. du Toit,et al.  Opioid receptors and cardioprotection – ‘opioidergic conditioning’ of the heart , 2015, British journal of pharmacology.

[10]  E. Prossnitz,et al.  Effects of Atrazine on Estrogen Receptor α– and G Protein–Coupled Receptor 30–Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts , 2015, Environmental health perspectives.

[11]  F. Spinella,et al.  Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cells. , 2014, Life sciences.

[12]  A. Belfiore,et al.  GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts. , 2014, Endocrine-related cancer.

[13]  Zhuojia Chen,et al.  The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo , 2014, Cell Death and Disease.

[14]  H. Chander,et al.  Abstract 4053: Formin-binding protein-17 (FBP17) is a target of p53 and promotes invadopodia formation in breast cancer cells , 2014 .

[15]  E. Prossnitz,et al.  G Protein–Coupled Estrogen Receptor Regulates Mammary Tumorigenesis and Metastasis , 2014, Molecular Cancer Research.

[16]  S. Rho,et al.  The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression , 2014, Oncotarget.

[17]  M. Pellegrino,et al.  GPER mediates activation of HIF1α/VEGF signaling by estrogens. , 2014, Cancer research.

[18]  M. Maggiolini,et al.  GPER Function in Breast Cancer: An Overview , 2014, Front. Endocrinol..

[19]  M. Fernö,et al.  Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer , 2014, Breast Cancer Research and Treatment.

[20]  M. Wu,et al.  Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells , 2014, Oncogene.

[21]  Haien Zhao,et al.  Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1α Activation in Human Osteosarcoma , 2014, PloS one.

[22]  Z. Ignatova,et al.  GPER functions as a tumor suppressor in triple-negative breast cancer cells , 2014, Journal of Cancer Research and Clinical Oncology.

[23]  Christine Weissenborn,et al.  GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells , 2014, Journal of Cancer Research and Clinical Oncology.

[24]  G. Dorn,et al.  Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2. , 2013, The Journal of clinical investigation.

[25]  V. Conti,et al.  Adrenergic signaling and oxidative stress: a role for sirtuins? , 2013, Front. Physiol..

[26]  Stephen Henderson,et al.  The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis , 2013, Clinical Cancer Research.

[27]  M. Maggiolini,et al.  HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) , 2013, Breast Cancer Research.

[28]  M. Maggiolini,et al.  GPER Mediates Cardiotropic Effects in Spontaneously Hypertensive Rat Hearts , 2013, PloS one.

[29]  P. Bagnoli,et al.  Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization , 2013, Journal of Molecular Medicine.

[30]  D. Dang,et al.  Regulation of Hypoxia-inducible Factor 1α (HIF-1α) by Lysophosphatidic Acid Is Dependent on Interplay between p53 and Krüppel-like Factor 5* , 2013, The Journal of Biological Chemistry.

[31]  C. Huang,et al.  β2-AR-HIF-1α: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis. , 2013, Current molecular medicine.

[32]  A. Roessner,et al.  GPER-1 Expression Decreases During Breast Cancer Tumorigenesis , 2013, Cancer investigation.

[33]  R. Dacey,et al.  G Protein–Coupled Estrogen Receptor Agonist Improves Cerebral Microvascular Function After Hypoxia/Reoxygenation Injury in Male and Female Rats , 2013, Stroke.

[34]  A. Belfiore,et al.  Insulin-like growth factor-I regulates GPER expression and function in cancer cells , 2013, Oncogene.

[35]  V. Farini,et al.  β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines , 2013, Laboratory Investigation.

[36]  Sung-Chun Tang,et al.  Stroke Increases G Protein-Coupled Estrogen Receptor Expression in the Brain of Male but Not Female Mice , 2012, Neurosignals.

[37]  A. Belfiore,et al.  New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer. , 2012, Cellular signalling.

[38]  F. Otterbach,et al.  New Insight into the SDF-1/CXCR4 Axis in a Breast Carcinoma Model: Hypoxia-Induced Endothelial SDF-1 and Tumor Cell CXCR4 Are Required for Tumor Cell Intravasation , 2012, Molecular Cancer Research.

[39]  C. Rosano,et al.  Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts , 2012, Environmental health perspectives.

[40]  G. Semenza Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. , 2012, Trends in pharmacological sciences.

[41]  Kyeong Lee,et al.  Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. , 2012, European journal of medicinal chemistry.

[42]  W. Chai,et al.  Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system , 2012, Neuroscience.

[43]  E. Prossnitz,et al.  GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure. , 2011, Immunology, endocrine & metabolic agents in medicinal chemistry.

[44]  E. Prossnitz,et al.  The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. , 2011, Vascular pharmacology.

[45]  A. Roessner,et al.  G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer , 2011, Breast Cancer Research and Treatment.

[46]  S. Andò,et al.  The G Protein-coupled Receptor 30 Is Up-regulated by Hypoxia-inducible Factor-1α (HIF-1α) in Breast Cancer Cells and Cardiomyocytes* , 2011, The Journal of Biological Chemistry.

[47]  K. Miyazono,et al.  LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. , 2010, Blood.

[48]  H. Randeva,et al.  G-protein coupled estrogen receptor 1 expression in rat and human heart: Protective role during ischaemic stress. , 2010, International journal of molecular medicine.

[49]  D. Meldrum,et al.  Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. , 2010, Surgery.

[50]  N. Joste,et al.  GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer , 2010, Breast Cancer Research and Treatment.

[51]  A. Molinolo,et al.  Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma , 2010, Proceedings of the National Academy of Sciences.

[52]  M. Maggiolini,et al.  Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. , 2010, Cancer research.

[53]  G. Czibik Complex role of the HIF system in cardiovascular biology , 2010, Journal of Molecular Medicine.

[54]  C. Rosano,et al.  Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells , 2010, Molecular and Cellular Endocrinology.

[55]  Bing Zhang,et al.  Estradiol and G1 Reduce Infarct Size and Improve Immunosuppression after Experimental Stroke , 2010, The Journal of Immunology.

[56]  E. Murphy,et al.  Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. , 2010, Trends in cardiovascular medicine.

[57]  Tudor I. Oprea,et al.  The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. , 2010, Cancer research.

[58]  M. Maggiolini,et al.  The unfolding stories of GPR30, a new membrane-bound estrogen receptor. , 2010, The Journal of endocrinology.

[59]  E. Murphy,et al.  Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. , 2009, American journal of physiology. Heart and circulatory physiology.

[60]  S. Fuqua,et al.  G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells. , 2009, Molecular endocrinology.

[61]  Gerhard Christofori,et al.  The angiogenic switch in carcinogenesis. , 2009, Seminars in cancer biology.

[62]  N. Joste,et al.  GPR30 predicts poor survival for ovarian cancer. , 2009, Gynecologic oncology.

[63]  M. Chappell,et al.  Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. , 2009, Endocrinology.

[64]  S. Rasmussen,et al.  The structure and function of G-protein-coupled receptors , 2009, Nature.

[65]  Didier Picard,et al.  Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF , 2009, The EMBO journal.

[66]  S. Andò,et al.  Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. , 2008, Endocrinology.

[67]  John Ross,et al.  Myocardial expression, signaling, and function of GPR22: a protective role for an orphan G protein-coupled receptor. , 2008, American journal of physiology. Heart and circulatory physiology.

[68]  R. Glaser,et al.  Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression , 2008, Brain, Behavior, and Immunity.

[69]  Tudor I. Oprea,et al.  Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. , 2007, The Journal of endocrinology.

[70]  Meenakshi Singh,et al.  GPR30: a novel indicator of poor survival for endometrial carcinoma. , 2007, American journal of obstetrics and gynecology.

[71]  J. Gutkind,et al.  G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.

[72]  D. Giri,et al.  Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression , 2006, Clinical Cancer Research.

[73]  G. Brewer Anticopper therapy against cancer and diseases of inflammation and fibrosis. , 2005, Drug discovery today.

[74]  M. Miyasaka,et al.  Chemokines in tumor progression and metastasis , 2005, Cancer science.

[75]  M. Burdick,et al.  Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. , 2005, Cancer research.

[76]  G. Semenza,et al.  Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. , 2005, Blood.

[77]  S. Andò,et al.  The G Protein-coupled Receptor GPR30 Mediates c-fos Up-regulation by 17β-Estradiol and Phytoestrogens in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.

[78]  L. Devi,et al.  Functional interactions between mu opioid and alpha 2A-adrenergic receptors. , 2003, Molecular pharmacology.

[79]  R. Bicknell,et al.  The FASEB Journal express article 10.1096/fj.02-0993fje. Published online June 17, 2003. Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia , 2022 .

[80]  D. Mukhopadhyay,et al.  Heterotrimeric Gαq/Gα11 Proteins Function Upstream of Vascular Endothelial Growth Factor (VEGF) Receptor-2 (KDR) Phosphorylation in Vascular Permeability Factor/VEGF Signaling* , 2003, Journal of Biological Chemistry.

[81]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[82]  S. Rafii,et al.  Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. , 2003, Cancer cell.

[83]  F. Spinella,et al.  Endothelin-1 Induces Vascular Endothelial Growth Factor by Increasing Hypoxia-inducible Factor-1α in Ovarian Carcinoma Cells* , 2002, The Journal of Biological Chemistry.

[84]  K. Webster,et al.  Molecular Regulation of the Endothelin-1 Gene by Hypoxia , 2001, The Journal of Biological Chemistry.

[85]  J. Pouysségur,et al.  Angiogenesis and G-protein-coupled receptors: signals that bridge the gap , 2001, Oncogene.

[86]  J. P. Hobson,et al.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.

[87]  J. Gutkind,et al.  The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.

[88]  R. Strieter,et al.  CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[89]  G. Semenza,et al.  Structural and functional analysis of hypoxia-inducible factor 1. , 1997, Kidney international.

[90]  G. Semenza,et al.  General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[91]  M. Maggiolini,et al.  G protein-coupled receptors: novel targets for drug discovery in cancer , 2010, Nature Reviews Drug Discovery.

[92]  K. Xie,et al.  HIF-1α links β-adrenoceptor agonists and pancreatic cancer cells under normoxic condition , 2010, Acta Pharmacologica Sinica.

[93]  R. Lefkowitz,et al.  Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.

[94]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[95]  木村 征靖 Orphan G protein-coupled receptor,GPR41,induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation , 2001 .

[96]  J. Gutkind,et al.  The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.